Zurcher Kantonalbank (Zurich Cantonalbank) Alx Oncology Holdings Inc Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

  • $32.8 Billion
  • Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 1,244 shares of ALXO stock, worth $2,226. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,244
Previous 1,244 -0.0%
Holding current value
$2,226
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
SELL
$1.81 - $8.13 $9,544 - $42,869
-5,273 Reduced 80.91%
1,244 $2,000
Q2 2024

Jul 29, 2024
BUY
$5.84 - $17.56 $30,368 - $91,312
5,200 Added 394.84%
6,517 $39,000
Q1 2024

Apr 25, 2024
SELL
$10.95 - $16.79 $6,460 - $9,906
-590 Reduced 30.94%
1,317 $14,000
Q4 2023

Jan 30, 2024
BUY
$4.81 - $15.38 $9,172 - $29,329
1,907 New
1,907 $28,000
Q4 2022

Feb 01, 2023
SELL
$9.51 - $12.95 $35,500 - $48,342
-3,733 Reduced 71.32%
1,501 $16,000
Q3 2022

Nov 09, 2022
BUY
$8.23 - $15.14 $43,075 - $79,242
5,234 New
5,234 $50,000
Q1 2022

Apr 21, 2022
SELL
$13.65 - $22.06 $8,340 - $13,478
-611 Closed
0 $0
Q4 2021

Feb 01, 2022
SELL
$21.49 - $74.4 $1,375 - $4,761
-64 Reduced 9.48%
611 $13,000
Q3 2021

Nov 15, 2021
BUY
$52.51 - $80.91 $262 - $404
5 Added 0.75%
675 $50,000
Q1 2021

May 03, 2021
BUY
$62.84 - $87.68 $42,102 - $58,745
670 New
670 $49,000

Others Institutions Holding ALXO

# of Institutions
101
Shares Held
39.7M
Call Options Held
134K
Put Options Held
17.4K
View Full List

About ALX ONCOLOGY HOLDINGS INC

ALXO Quotes by TradingView
  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $72.9M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email